Navigation Links
Biosimilars Market Entry Strategies - For Pharma Companies, Biosimilars Offer a Relatively Low Risk Growth Strategy

DALLAS, December 26, 2011 /PRNewswire/ --

ReportsnReports adds new market research report 'Biosimilars : Market Entry Strategies' to its store. This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.

  • Of the companies analyzed, each of the eight generics companies ranked among the top 50 pharma companies have an active interest in biosimilars, reflecting the fact that such products have the opportunity to increase the profit margin of generics companies.
  • Many innovative pharma companies have also entered the biosimilars arena with further companies such as Boehringer Ingelheim showing signs of interest.
  • However, a number of companies such as AstraZeneca, Bayer, and Roche have stated that they have no plans to enter the biosimilars market, instead maintaining their innovative focus.

Study Comprehensive Table of Contents and Request a Sample for the report @

With sales for the top 50 pharma companies forecast to decline by 1.6% during 2010-16, many leading drugmakers are looking to expand into markets which offer long-term growth, limited competition, and are relatively low risk. Biosimilars is one such area, which has attracted both innovative biologics players and generics players alike.

Features and benefits

  • Insight into why pharma are tapping into the biosimilars market
  • Analysis of biosimilar deal trends among the top 50 pharma companies
  • Insight into the top 50 pharma companies active in biosimilars
  • Review of the top 50 pharma companies that plan to enter the biosimilars market in the near future
  • Summary of the top 50 pharma companies plan to avoid biosimilars

Your key questions answered

  • Understand how and why different corporate pharma companies are targeting biosimilars
  • Examine why some companies have opted not to enter this sector

Inquire Before Buying or get your copy of the report on Biosimilars Market Entry Strategies.

Find other newly published market research reports @

About Us: is an online market research library of 135,000+ reports and in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Visit for more details.

Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
Visit our Market Research Blog @

SOURCE ReportsnReports
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Leading Indian CRO Max Neeman International Expands in Response to Positive Biosimilars Market in India
2. Multi-therapy Drugs: Opportunities for Generics & Biosimilars
3. Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
4. Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
5. Reportlinker Adds Global Biosimilars (Follow-on biologics) Market: An Analysis
6. Oncologists Will Be More Aggressive In Adopting Biosimilars Compared With Other Specialties
7. PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers
8. Decision Resources Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars
9. ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report
10. Orphan Drug Markets in Europe
11. Global Markets for Laser Systems, Components and Materials -- Focus on Asia-Pacific
Post Your Comments:
(Date:11/27/2015)... , Niederlande, November 27, 2015 ... fotodynamischer Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   --> ... Bremachlorin-Therapie bei fortgeschrittenem Krebs.   Clinical ... --> Clinical Cancer Research vom ...
(Date:11/26/2015)... 26, 2015 Un nuevo enfoque ... para el cáncer avanzado.   --> ... fotodinámica de Bremachlorin para el cáncer avanzado.   ... inmunoterapia con la terapia fotodinámica de Bremachlorin para el ... . --> Clinical Cancer Research . ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and Markets ... "Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - Rise ... the Demand " report to their offering. ... --> Boston scientific and others. ... players including Medtronic, Biotronik, Boston scientific ...
Breaking Medicine Technology:
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... new study carried out by the University of Toronto and the University of British ... number of hospitalizations for head injuries. The article explains that part of the reason ...
(Date:11/27/2015)... ... 2015 , ... A team of Swiss doctors has released a report on ... just posted the findings on the website. Click here to read the details ... mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the 106 ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion ... off of their purchase of lice treatment product. In addition, customers will receive a ... company spokesperson. “Finding lice is a sure way to ruin the holidays, so we ...
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
Breaking Medicine News(10 mins):